first large study of glp-1 receptor agonists during pregnancy Frontiers Continuation of GLP-1 Receptor Agonist
Description
Your role during the MDL While the MDL proceeds, your primary responsibilities are straightforward
In 2024, the United States budgeted nearly $44.5 billion for drug control
PMID: 36 KrisanapanPSuppadungsukSSanpawithayakulKThongprayoonCPattharanitimaPTangpanithandeeSet al
As part of the evolving R&D pipeline, Figure 3 summarises the emerging research frontiers into the potential therapeutic applications of GLP-1s beyond cardiometabolic conditions, including neurodegeneration, addiction, mental health, cancer, womens health and asthma
Recent studies have also explored the ocular risks associated with GLP-1 therapies
[2] Drucker, D
